Literature DB >> 29101576

Trends in Community Versus Health Care-Acquired Methicillin-Resistant Staphylococcus aureus Infections.

David P Calfee1,2.   

Abstract

Since the first clinical isolate of methicillin-resistant Staphylococcus aureus was described in 1961, this pathogen has established itself as a leading cause of health care-associated infections. More recently, MRSA has become a relatively common cause of infection among persons without typical health care-associated risk factors and is now the most common cause of community-onset purulent skin and soft-tissue infections in many regions of the USA. The appearance of "community-associated" MRSA is not due to the expansion of health care-associated MRSA into the community but rather the result of the independent emergence of a novel clone of MRSA. There are some encouraging data to suggest that the incidence of MRSA infection, particularly invasive infections, is decreasing in the USA, but this pathogen remains a common cause of infection associated with substantial morbidity and mortality. Thus, there is ongoing need for effective and safe prevention, diagnosis, and treatment strategies.

Entities:  

Keywords:  Antimicrobial resistance; Epidemiology; Infection; Methicillin resistance; Staphylococcus aureus

Year:  2017        PMID: 29101576     DOI: 10.1007/s11908-017-0605-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  28 in total

1.  Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).

Authors:  Helio S Sader; Rodrigo E Mendes; Ronald N Jones; Robert K Flamm
Journal:  Diagn Microbiol Infect Dis       Date:  2016-06-23       Impact factor: 2.803

2.  Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-08-20       Impact factor: 17.586

3.  Eight years of decreased methicillin-resistant Staphylococcus aureus health care-associated infections associated with a Veterans Affairs prevention initiative.

Authors:  Martin E Evans; Stephen M Kralovic; Loretta A Simbartl; Rajiv Jain; Gary A Roselle
Journal:  Am J Infect Control       Date:  2017-01-01       Impact factor: 2.918

4.  Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.

Authors:  Rajiv Jain; Stephen M Kralovic; Martin E Evans; Meredith Ambrose; Loretta A Simbartl; D Scott Obrosky; Marta L Render; Ron W Freyberg; John A Jernigan; Robert R Muder; LaToya J Miller; Gary A Roselle
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

Review 6.  Life After USA300: The Rise and Fall of a Superbug.

Authors:  Paul J Planet
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

7.  National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011.

Authors:  Raymund Dantes; Yi Mu; Ruth Belflower; Deborah Aragon; Ghinwa Dumyati; Lee H Harrison; Fernanda C Lessa; Ruth Lynfield; Joelle Nadle; Susan Petit; Susan M Ray; William Schaffner; John Townes; Scott Fridkin
Journal:  JAMA Intern Med       Date:  2013-11-25       Impact factor: 21.873

8.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.

Authors:  Lindsey M Weiner; Amy K Webb; Brandi Limbago; Margaret A Dudeck; Jean Patel; Alexander J Kallen; Jonathan R Edwards; Dawn M Sievert
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

9.  Vancomycin-Resistant Staphylococcus aureus - Delaware, 2015.

Authors:  Maroya Spalding Walters; Paula Eggers; Valerie Albrecht; Tatiana Travis; David Lonsway; Greg Hovan; Debra Taylor; Kamile Rasheed; Brandi Limbago; Alexander Kallen
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-09-25       Impact factor: 17.586

10.  Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States.

Authors:  Brandi M Limbago; Alexander J Kallen; Wenming Zhu; Paula Eggers; Linda K McDougal; Valerie S Albrecht
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

View more
  11 in total

1.  Increasing Multidrug Antibiotic Resistance in MRSA Infections of the Hand: A 10-Year Analysis of Risk Factors.

Authors:  Justin M Kistler; Colin M Vroome; Frederick V Ramsey; Asif M Ilyas
Journal:  Hand (N Y)       Date:  2019-03-22

2.  Antibiotic resistance profile and molecular characterization of Staphylococcus aureus strains isolated in hospitals in Kabul, Afghanistan.

Authors:  Frédéric Laurent; Céline Dupieux; Haji Mohammad Naimi; Camille André; Michèle Bes; Anne Tristan; Claude-Alexandre Gustave; François Vandenesch; Qand Agha Nazari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-03       Impact factor: 3.267

3.  Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus.

Authors:  Zhanwen Wang; Zhiwei Lin; Bing Bai; Guangjian Xu; Peiyu Li; Zhijian Yu; Qiwen Deng; Yongpeng Shang; Jinxin Zheng
Journal:  BMC Microbiol       Date:  2020-07-01       Impact factor: 3.605

4.  Preoperative screening for nasal carriage of methicillin-resistant Staphylococcus aureus in patients undergoing general thoracic surgery.

Authors:  Yoshimasa Mizuno; Koyo Shirahashi; Hirotaka Yamamoto; Mitsuyoshi Matsumoto; Yusaku Miyamoto; Hiroyasu Komuro; Kiyoshi Doi; Hisashi Iwata
Journal:  J Rural Med       Date:  2019-05-30

5.  Risk factors for wound infection caused by Methicillin Resistant Staphylococcus aureus among hospitalized patients: a case control study from a tertiary care hospital in India.

Authors:  Latha Thimmappa; Anil Bhat; Manjunatha Hande; Chiranjay Mukhopadhyay; Elsa Devi; Baby Nayak; Anice George
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

6.  Lipoproteins from Staphylococcus aureus Drive Neutrophil Extracellular Trap Formation in a TLR2/1- and PAD-Dependent Manner.

Authors:  Jessica S Hook; Parth A Patel; Aidan O'Malley; Lihua Xie; Jeffrey S Kavanaugh; Alexander R Horswill; Jessica G Moreland
Journal:  J Immunol       Date:  2021-07-21       Impact factor: 5.422

Review 7.  Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance.

Authors:  Kushal Vanamala; Katyayani Tatiparti; Ketki Bhise; Samaresh Sau; Marc H Scheetz; Michael J Rybak; David Andes; Arun K Iyer
Journal:  Drug Discov Today       Date:  2020-10-20       Impact factor: 7.851

Review 8.  Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.

Authors:  Alan Hibbitts; Cian O'Leary
Journal:  Materials (Basel)       Date:  2018-02-23       Impact factor: 3.623

9.  High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus.

Authors:  Alessandra Oliva; Silvia Costantini; Massimiliano De Angelis; Stefania Garzoli; Mijat Božović; Maria Teresa Mascellino; Vincenzo Vullo; Rino Ragno
Journal:  Molecules       Date:  2018-10-09       Impact factor: 4.411

10.  In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding Protein.

Authors:  Bing Bai; Zhiwei Lin; Zhangya Pu; Guangjian Xu; Fan Zhang; Zhong Chen; Xiang Sun; Jinxin Zheng; Peiyu Li; Qiwen Deng; Zhijian Yu
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.